ABIONYX Pharma
Healthcare
HQ: Balma, France
Investors: 1
Develops HDL therapies for treating kidney and ophthalmologic diseases
Investors (1)
| Fund | Status | Entry Date | Stage | Source |
|---|---|---|---|---|
| Sofinnova Partners | Current | - | - | Website |
Develops HDL therapies for treating kidney and ophthalmologic diseases
| Fund | Status | Entry Date | Stage | Source |
|---|---|---|---|---|
| Sofinnova Partners | Current | - | - | Website |